Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) vs 10X Genomics Inc (TXG) Price & Performance

SP Funds S&P 500 Sharia Industry Exclusions ETFTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

SP Funds S&P 500 Sharia Industry Exclusions ETF vs 10X Genomics Inc — how do they compare? SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $59.15, while 10X Genomics Inc trades at $59.24 (market cap $7.61B). Which is the better fit depends on your goals.

SPUSTXG
Sector
Broad Market / FactorHealth
52-Week High
$59.51$58.57
52-Week Low
$46.28$11.34
Market Cap
$7.61B
Enterprise Value
$7.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SP Funds S&P 500 Sharia Industry Exclusions ETF

SPUS trades at $59.16, up 0.82% today, with a bullish technical signal from moving averages but bearish oscillators. Recent dividends of $0.03 per share were declared for mid-2026. The stock shows strong institutional interest and competitive dividend strategies amid market concentration in tech stocks.

Outlook remains positive due to dividend stability and technical support, but overbought RSI signals caution. Risks include market volatility and reliance on dividend performance. Analysts monitor earnings growth as a key catalyst for sustained upside.

10X Genomics Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About SP Funds S&P 500 Sharia Industry Exclusions ETF

SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.

Read more on SPUS

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG